サイト内検索SEARCH

業績

HOME > 業績 > Dasatinib and Quercetin as Senolytic Drugs Improve Fat Deposition and Exhibit Antifibrotic Effects in the Medaka Metabolic Dysfunction-Associated Steatotic Liver Disease Model
  • 原著 Dasatinib and Quercetin as Senolytic Drugs Improve Fat Deposition and Exhibit Antifibrotic Effects in the Medaka Metabolic Dysfunction-Associated Steatotic Liver Disease Model
    Yakubo S, Abe H, Li Y, Kudo M, Kimura A, Wakabayashi T, Watanabe Y, Kimura N, Setsu T, Yokoo T, Sakamaki A, Kamimura H, Tsuchiya A, Kamimura K, Terai S.
    Diseases. 2024 Dec 4;12(12):317. doi: 10.3390/diseases12120317.
一覧に戻る